Focus on population health outcomes and disease prevention metrics across all interventions.
157%
Return on Investment
Over 10 years
20.4B
Total Investment (AED)
Across all interventions
158,080
Disease Events Prevented
Major health events
16,325
Deaths Averted
Premature deaths averted
📈 Break-Even Analysis
Investment becomes cost-neutral and begins generating positive returns
Year 1
Initial Investment
Initial Investment
Year 4.2
Break-Even Point
Break-Even Point
Year 7
2x Return
2x Return
Year 10
157% ROI
157% ROI
Break-even achieved in 4.2 years - Based on UAE-specific disease progression models and productivity impact analysis
📊 Direct Savings:
AED 40.5B healthcare costs avoided
AED 40.5B healthcare costs avoided
💼 Productivity Gains:
AED 11.9B workforce preserved
AED 11.9B workforce preserved
🏥 Early ROI Drivers:
Premature disease onset at age 45
Premature disease onset at age 45
📊 Cost-Benefit Analysis by Intervention
🎯 Population Health Impact
⏱️ ROI Timeline Projection
💵 Cost-Effectiveness Comparison
🎯 Intervention Portfolio Summary
Cardiovascular Disease Prevention
180% ROI
Target: 500K high-risk adults
Cost/QALY: AED 61,400
Events prevented: 12,450
Cost/QALY: AED 61,400
Events prevented: 12,450
Type 2 Diabetes Prevention
110% ROI
Target: 750K pre-diabetic adults
Cost/QALY: AED 32,100
New cases prevented: 127,500
Cost/QALY: AED 32,100
New cases prevented: 127,500
Cancer Screening Programs
85% ROI
Breast & Colorectal screening
Cost/QALY: AED 42,250
Deaths averted: 3,100
Cost/QALY: AED 42,250
Deaths averted: 3,100
Osteoporosis Prevention
84% ROI
Target: 234K at-risk adults
Cost-saving intervention
Fractures prevented: 10,530
Cost-saving intervention
Fractures prevented: 10,530
Alzheimer's Prevention
60% ROI
Target: 30K high-risk elderly
Cost/QALY: AED 48,900
Onset delayed: 2,700 cases
Cost/QALY: AED 48,900
Onset delayed: 2,700 cases